Starting in investment banking, Helen spent 8 years at 3i plc focusing on MBO and growth capital investments. She co-founded Matrix Private Equity raising a successful technology fund, the Matrix Venture Fund VCT plc and a generalist fund, the Matrix Enterprise Fund. She subsequently became Managing Director of Matrix Private Equity before moving to take on a portfolio of roles in 2004. She is a Non-Executive Director of Hotbed Fund Managers Ltd, The Income & Growth VCT plc and Matrix Income & Growth 4 VCT plc and is an appointed advisor to the fund manager of Trapezia Capital Partners II LP and the Creative Capital Fund.
Has over 20 years of industrial experience in engineering and technology orientated industries and has worked in both the USA and the UK. He has spent the last 23 years in the venture capital industry and was chairman of YFM Private Equity Limited and a director of YFM Group Limited until 3 April 2008. He has been responsible for a wide range of venture capital deals in a variety of industries including hi-tech, software, computer maintenance, engineering, printing, safety equipment, design and textiles. He is a non-executive director of British Smaller Technology Companies VCT 2 plc and was appointed to the board of Pressure Technologies plc on 14 April 2008
Qualified as a chartered accountant with PricewaterhouseCoopers LLP. He is chairman of Xpertise Group plc, an AIM quoted IT training group, Knowledge Technology Solutions plc, an AIM listed IT software company and, on 1 January 2008, became chairman of British Smaller Technology Companies VCT 2 plc. He is a non-executive director of Patsystems plc and Financial Payment Systems Limited, both AIM quoted software companies, and Lighthouse plc, an AIM quoted provider of financial services.
Has more than 20 years experience in the development of emerging businesses and, in particular, the commercial exploitation of new technologies. He co-founded The Generics Group of companies (renamed Sagentia) in 1986, which is one of the country's leading technology consulting and investment groups and was a key member of the team that took the company public in December 2000. He retired from The Generics Group at the end of 2002 to pursue independent investment activities. He is an investor-director on the board of a number of technology companies, including Sphere Medical Limited, Timberpost Limited and Acal Energy Limited (of which he is Chairman). He is also a non-executive director of British Smaller Technology Companies VCT 2 plc.